Oxford COVID-19 vaccine trial begins in South Africa

South Africa // 25 June, 2020

Human trials of the ChAdOx1 nCoV-19, developed by the University of Oxford, have begun in South Africa. This will be the first COVID-19 vaccine trialed in Africa. Participants are being screened at the University of the Witwatersrand, Johannesburg, and will be vaccinated this week.

The same vaccine has already been given to over 4,000 people in the United Kingdom, with additional trials planned in Brazil and the United States.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars